The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-(6-fluoro-1H-indol-3-yl)-1-(piperazin-1-ylmethyl)-1H-benzo[d][1,2,3]triazole ID: ALA4875970
PubChem CID: 164625965
Max Phase: Preclinical
Molecular Formula: C20H21FN6
Molecular Weight: 364.43
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Fc1ccc2c(-c3ccc4nnn(CCN5CCNCC5)c4c3)c[nH]c2c1
Standard InChI: InChI=1S/C20H21FN6/c21-15-2-3-16-17(13-23-19(16)12-15)14-1-4-18-20(11-14)27(25-24-18)10-9-26-7-5-22-6-8-26/h1-4,11-13,22-23H,5-10H2
Standard InChI Key: NWBMXBXPSXUWBK-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 31 0 0 0 0 0 0 0 0999 V2000
29.5619 -13.8716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5608 -14.6911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2688 -15.1001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2670 -13.4627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9757 -13.8680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9804 -14.6866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7605 -14.9350 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.2378 -14.2699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7527 -13.6105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0007 -12.8319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8008 -12.6620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6964 -11.4572 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4520 -12.2348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5008 -11.2762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0460 -11.8819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7905 -11.5506 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.7055 -10.7401 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.9084 -10.5706 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.4981 -11.9594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4979 -12.7765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2055 -13.1853 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.2031 -14.0002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9066 -14.4089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6168 -14.0040 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.6190 -13.1858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9109 -12.7726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8527 -15.0992 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
9 10 1 0
10 11 2 0
11 15 1 0
14 12 1 0
12 13 2 0
13 10 1 0
14 15 2 0
15 16 1 0
16 17 1 0
17 18 2 0
18 14 1 0
16 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
21 26 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
2 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 364.43Molecular Weight (Monoisotopic): 364.1812AlogP: 2.62#Rotatable Bonds: 4Polar Surface Area: 61.77Molecular Species: BASEHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 9.24CX LogP: 2.80CX LogD: 0.96Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.58Np Likeness Score: -1.54
References 1. Kozlova A, Thabault L, Liberelle M, Klaessens S, Prévost JRC, Mathieu C, Pilotte L, Stroobant V, Van den Eynde B, Frédérick R.. (2021) Rational Design of Original Fused-Cycle Selective Inhibitors of Tryptophan 2,3-Dioxygenase., 64 (15.0): [PMID:34338527 ] [10.1021/acs.jmedchem.1c00323 ]